Newsroom

Sorted by: Latest

-

ADOCIA Presents Preclinical Data at ObesityWeek® 2026 Confirming the Potential of AdoXLong™ for Monthly Injections of Peptides

LYON, France--(BUSINESS WIRE)--Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC, the “Company”), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment of metabolic diseases including diabetes and obesity, today announces the presentation of preclinical data in poster format on its AdoXLong™ platform applied to semaglutide, AdoXL Sema, at ObesityWeek® 2026, taking place in Washington, USA, November 14-...
-

ADOCIA présente des données précliniques à l’ObesityWeek 2026® confirmant le potentiel d’AdoXLong™ pour des injections mensuelles de peptides

LYON, France--(BUSINESS WIRE)--Regulatory News: Adocia (Euronext Paris : FR0011184241 – ADOC, la « Société »), société biopharmaceutique au stade clinique spécialisée dans la recherche et le développement de solutions thérapeutiques innovantes pour le traitement des maladies métaboliques, notamment le diabète et l’obésité, annonce aujourd’hui la présentation sous forme de poster des données précliniques sur sa plateforme AdoXLong™ appliquée au sémaglutide, AdoXL Sema, lors du congrès ObesityWee...
-

Aelis Farma reçoit une deuxième recommandation favorable du Comité indépendant de surveillance des données (IDMC) pour son étude de Phase 2b avec AEF0217 chez des personnes avec une trisomie 21

BORDEAUX, France--(BUSINESS WIRE)--Regulatory News: Aelis Farma (ISIN : FR0014007ZB4 – Mnémonique : AELIS, éligible PEA-PME), société biopharmaceutique au stade clinique spécialisée dans le développement de traitements pour les maladies du cerveau et périphériques impliquant le récepteur CB1 du système endocannabinoïde, annonce aujourd’hui une deuxième recommandation favorable du Comité indépendant de surveillance des données (« IDMC »), après examen des données de sécurité de l’étude de Phase...
-

Aelis Farma Receives a Second Positive Recommendation From the Independent Data Monitoring Committee for Its Phase 2b Study with AEF0217 in People With Down syndrome

BORDEAUX, France--(BUSINESS WIRE)--Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specializing in the development of treatments for diseases involving the CB1 receptor, today announces a second positive recommendation from the Independent Data Monitoring Committee ("IDMC") reviewing the safety data of the ongoing Phase 2b study with AEF0217 in adults and older adolescents (16-17 years of age) with Down syndrome. Following this revie...
-

Carmila accélère en Italie par un rapprochement amical avec IGD 

BOULOGNE-BILLANCOURT, France--(BUSINESS WIRE)--Regulatory News: Carmila annonce aujourd'hui son intention de renforcer sa présence en Italie par le biais d’un rapprochement amical avec IGD, le leader italien du secteur qui détient 25 centres commerciaux d'une valeur de 1,9 milliard d'euros1. Cette opération stratégique générera une croissance relutive et offrira une création de valeur immédiate pour les actionnaires des deux groupes. Carmila et Coop Alleanza 3.0, l'actionnaire principal d'IGD,...
-

Carmila Accelerates in Italy by Combining With IGD in a Friendly Transaction

BOULOGNE-BILLANCOURT, France--(BUSINESS WIRE)--Regulatory News: Carmila today announces its ambition to scale its Italian footprint through a friendly transaction to combine with IGD, the Italian leading player owning 25 shopping centres valued at c.€1.9 billion1. This strategic move will drive accretive growth and deliver immediate value for both shareholder groups. Carmila and Coop Alleanza 3.0, IGD’s main shareholder, signed an agreement under which Coop Alleanza 3.0 will contribute its 40.9...
-

SkyDrive Wins Best Paper Award at VFS Heli Japan 2026

TOYOTA, Japan--(BUSINESS WIRE)--SkyDrive Inc. (“SkyDrive”), a leading compact eVTOL aircraft (*1) developer based in Japan, announced that a technical paper presented by its Aeronautics Development Department won the prestigious Best Paper Award at the 12th Asian / Australian Rotorcraft Forum / Heli Japan 2026, held in Gifu, Japan, and organized by the Vertical Flight Society (VFS), the world’s leading technical community dedicated to vertical flight. SkyDrive aims “to take the lead in the once...
-

Genentech’s Gazyva Becomes the First FDA-Approved Treatment for Primary Membranous Nephropathy

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab) for the treatment of adult patients with primary membranous nephropathy (pMN) at risk of disease progression, to induce remission of proteinuria. Gazyva becomes the first and only therapy to receive FDA approval for this disease, having previously been granted Breakthrough Therapy D...
-

Finite State to Reveal Results of Six-Month, AI-Driven Firmware Security Research at Hardwear.io 2026

AMSTERDAM & COLUMBUS, Ohio--(BUSINESS WIRE)--Finite State, a leader in product security and software supply chain risk management, today announced that Roland Lindsey, Chief Product Security Engineer, will present findings from six months of intensive firmware security research at Hardwear.io Netherlands 2026, taking place November 19–20 at the Amsterdam Marriott Hotel.The 90-minute technical session, "140+ Detonations: What Six Months of LLM-Driven Firmware Teardowns Actually Proved," will exam...
-

Xsolla Opens the Xsolla Clubhouse, an Industry Networking Lounge in Busan During G-STAR 2026

SEOUL, South Korea--(BUSINESS WIRE)--Xsolla (USA), Inc., a global commerce company that helps developers launch, grow, and monetize their games, will run the Xsolla Clubhouse in the 5th floor ballroom of the Grand Josun Busan on November 19 and 20, during G-STAR 2026. The Xsolla Clubhouse is a business lounge for people across the video game industry, with a meeting space to discuss growth strategies with Xsolla experts and a relaxed space to connect and take a break. Any G-STAR attendee can dr...